44 related articles for article (PubMed ID: 11078798)
1. Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers.
Suzuki T; Aoki D; Susumu N; Udagawa Y; Nozawa S
Int J Oncol; 2000 Dec; 17(6):1131-9. PubMed ID: 11078798
[TBL] [Abstract][Full Text] [Related]
2. Expression of nodal signalling components in cycling human endometrium and in endometrial cancer.
Papageorgiou I; Nicholls PK; Wang F; Lackmann M; Makanji Y; Salamonsen LA; Robertson DM; Harrison CA
Reprod Biol Endocrinol; 2009 Oct; 7():122. PubMed ID: 19874624
[TBL] [Abstract][Full Text] [Related]
3. Medicine. The cart before the horse.
Rowley JD; Blumenthal T
Science; 2008 Sep; 321(5894):1302-4. PubMed ID: 18772424
[No Abstract] [Full Text] [Related]
4. Analysis of the Expression of LSF Transcription Factor in the Regulation of Transcription and TSG101 during the Neoplastic Transformation of Endometrial Cells.
Ziemiński R; Stupak A; Kwiatek M; Gęca T; Warowicka A; Hejne K; Kwaśniewska A; Goździcka-Józefiak A; Kwaśniewski W
Cells; 2024 Mar; 13(7):. PubMed ID: 38607019
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling of mouse endometrial cancers microdissected from ethanol-fixed, paraffin-embedded tissues.
Kabbarah O; Pinto K; Mutch DG; Goodfellow PJ
Am J Pathol; 2003 Mar; 162(3):755-62. PubMed ID: 12598310
[TBL] [Abstract][Full Text] [Related]
6. Role of Leptin and Adiponectin in Endometrial Cancer.
Słabuszewska-Jóźwiak A; Lukaszuk A; Janicka-Kośnik M; Wdowiak A; Jakiel G
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628118
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling in reproduction.
Moldovan GE; Miele L; Fazleabas AT
Trends Endocrinol Metab; 2021 Dec; 32(12):1044-1057. PubMed ID: 34479767
[TBL] [Abstract][Full Text] [Related]
8. Proliferation of poorly differentiated endometrial cancer cells through autocrine activation of FGF receptor and HES1 expression.
Mori M; Mori T; Yamamoto A; Takagi S; Ueda M
Hum Cell; 2019 Jul; 32(3):367-378. PubMed ID: 30963412
[TBL] [Abstract][Full Text] [Related]
9. Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation.
Daley-Brown D; Oprea-Iles G; Vann KT; Lanier V; Lee R; Candelaria PV; Quarshie A; Pattillo R; Gonzalez-Perez RR
Dis Markers; 2017; 2017():8248175. PubMed ID: 28659656
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Lachej N; Dabkevičienė D; Sasnauskienė A; Trimonytė RM; Kanopienė D; Kazbarienė B; Didžiapetrienė J
Acta Med Litu; 2017; 24(1):35-43. PubMed ID: 28630591
[No Abstract] [Full Text] [Related]
11. Notch Signaling in Neuroendocrine Tumors.
Crabtree JS; Singleton CS; Miele L
Front Oncol; 2016; 6():94. PubMed ID: 27148486
[TBL] [Abstract][Full Text] [Related]
12. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
He S; Zeng S; Zhou ZW; He ZX; Zhou SF
Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
[TBL] [Abstract][Full Text] [Related]
13. Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition.
Espinoza I; Pochampally R; Xing F; Watabe K; Miele L
Onco Targets Ther; 2013 Sep; 6():1249-59. PubMed ID: 24043949
[TBL] [Abstract][Full Text] [Related]
14. Notch inhibitors for cancer treatment.
Espinoza I; Miele L
Pharmacol Ther; 2013 Aug; 139(2):95-110. PubMed ID: 23458608
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated expression of Notch signaling molecules in human endometrial cancer.
Jonusiene V; Sasnauskiene A; Lachej N; Kanopiene D; Dabkeviciene D; Sasnauskiene S; Kazbariene B; Didziapetriene J
Med Oncol; 2013 Mar; 30(1):438. PubMed ID: 23315219
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.
Huang X; Wang L; Zhang H; Wang H; Zhao X; Qian G; Hu J; Ge S; Fan X
PLoS One; 2012; 7(8):e44301. PubMed ID: 22937170
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells.
Mori M; Miyamoto T; Yakushiji H; Ohno S; Miyake Y; Sakaguchi T; Hattori M; Hongo A; Nakaizumi A; Ueda M; Ohno E
Hum Cell; 2012 Mar; 25(1):9-15. PubMed ID: 22189483
[TBL] [Abstract][Full Text] [Related]
18. Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.
McGowan PM; Simedrea C; Ribot EJ; Foster PJ; Palmieri D; Steeg PS; Allan AL; Chambers AF
Mol Cancer Res; 2011 Jul; 9(7):834-44. PubMed ID: 21665937
[TBL] [Abstract][Full Text] [Related]
19. Paradigms of notch signaling in mammals.
Dumortier A; Wilson A; MacDonald HR; Radtke F
Int J Hematol; 2005 Nov; 82(4):277-84. PubMed ID: 16298815
[TBL] [Abstract][Full Text] [Related]
20. The Notch pathway in ovarian carcinomas and adenomas.
Hopfer O; Zwahlen D; Fey MF; Aebi S
Br J Cancer; 2005 Sep; 93(6):709-18. PubMed ID: 16136053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
